We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQT icon
1026
EQT Corp
EQT
$34.2B
– –
-294,100
Closed -$18.7M
ERAS icon
1027
Erasca
ERAS
$5.49B
– –
-2,100,000
Closed -$34M
ESRT icon
1028
Empire State Realty Trust
ESRT
$734M
– –
-230,000
Closed -$1.2M
FE icon
1029
FirstEnergy
FE
$26.7B
– –
-886,700
Closed -$44.9M
FHN icon
1030
First Horizon
FHN
$11.6B
– –
-600,100
Closed -$13.7M
FITB
1031
Fifth Third Bancorp
FITB
$49.1B
– –
-776,297
Closed -$36.1M
FN icon
1032
Fabrinet
FN
$15B
– –
-27,500
Closed -$14.3M
FOLD
1033
DELISTED
Amicus Therapeutics
FOLD
– –
-1,650,000
Closed -$23.9M
GKOS icon
1034
Glaukos
GKOS
$10.6B
– –
-81,878
Closed -$8.81M
B
1035
Barrick Mining
B
$73.4B
– –
-250,000
Closed -$10.2M
GTLS
1036
DELISTED
Chart Industries
GTLS
– –
-296,469
Closed -$61.3M
HCA icon
1037
HCA Healthcare
HCA
$91.3B
– –
-116,200
Closed -$55M
HIG icon
1038
Hartford Financial Services
HIG
$37B
– –
-149,832
Closed -$20.3M
HOS
1039
Hornbeck Offshore Services, Inc.
HOS
$2.98B
– –
-300,000
Closed -$2.97M
HOLX
1040
DELISTED
Hologic
HOLX
– –
-858,013
Closed -$64.9M
IMVT icon
1041
Immunovant
IMVT
$8B
– –
-413,000
Closed -$10.3M
INO icon
1042
Inovio Pharmaceuticals
INO
$136M
– –
-804,958
Closed -$1.4M
IRTC icon
1043
iRhythm Holdings
IRTC
$3.94B
– –
-8,289
Closed -$978K
KMI icon
1044
Kinder Morgan
KMI
$69.9B
– –
-433,854
Closed -$14.5M
KMPR icon
1045
Kemper
KMPR
$1.6B
– –
-800,000
Closed -$24.4M
KNTK icon
1046
Kinetik
KNTK
$4.39B
– –
-362,500
Closed -$17.5M
KOS icon
1047
Kosmos Energy
KOS
$1.71B
– –
-150,000
Closed -$417K
KRP icon
1048
Kimbell Royalty Partners
KRP
$1.53B
– –
-365,000
Closed -$5.28M
LANV.WS
1049
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
– –
-64,733
Closed -$712
LEN icon
1050
Lennar Class A
LEN
$19.5B
– –
-142,517
Closed -$12.4M
40 41
42
43 44

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.